ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF (D) - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.966 USD | +0.97% |
|
+1.11% | -6.53% |
Investment objective
The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 397.5 USD | -0.06% | +0.81% | -2.31% | 8.46% | ||
| 883.2 USD | -0.84% | -1.52% | +0.56% | 7.85% | ||
| 270 USD | +0.22% | +0.39% | -6.26% | 7.84% | ||
| 65.42 USD | +0.23% | -2.01% | -19.24% | 7.77% | ||
| 208.9 USD | +3.18% | +7.47% | -19.27% | 3.86% | ||
| 108 USD | +1.69% | +6.47% | +8.57% | 3.85% | ||
| 143.3 USD | -0.28% | -0.76% | -25.13% | 2.51% | ||
| 122.3 USD | +1.02% | +4.13% | -12.18% | 2.31% | ||
| 80.91 USD | -1.53% | -8.71% | -16.09% | 1.87% | ||
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 5.966 | +0.97% | 0 |
| 25/24/25 | 5.909 | -2.01% | 0 |
| 24/24/24 | 6.03 | -0.32% | 16,425 |
| 23/24/23 | 6.05 | +2.23% | 23,617 |
| 22/24/22 | 5.918 | +0.29% | 10,286 |
Other stock markets
Delayed Quote London S.E.
Last update April 26, 2024 at 09:05 pm IST
More quotesDescription
| IE00BDZVHG35 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | NASDAQ Biotechnology Net Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
05/03/2018
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 28/03/2024 )
| AuM (EUR) | 41 M€ |
|---|---|
| AuM 1M | 42 M€ |
| AuM 3 months | 40 M€ |
| AuM 6 months | 36 M€ |
| AuM 12 months | 37 M€ |
- Stock Market
- ETF
- BTEE ETF
